Education
About Us
Working with TipRanks
Follow Us
Race Oncology Ltd. (AU:RAC)
ASX:RAC
RAC Stock Chart & Stats
AU$2.66
-AU$0.03(-2.27%)
At close: 4:00 PM EST
AU$2.66
-AU$0.03(-2.27%)
Day’s Range― - ―
52-Week RangeAU$0.92 - AU$4.90
Previous CloseN/A
Volume68.10K
Average Volume (3M)373.28K
Market Cap
AU$518.99M
Enterprise ValueAU$190.48M
Total Cash (Recent Filing)AU$13.67M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding178,348,250
10 Day Avg. Volume310,625
30 Day Avg. Volume373,283
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)12.69
Price to Sales (P/S)33.63
P/FCF Ratio-44.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Race Oncology Ltd. News
RAC FAQ
What was Race Oncology Ltd.’s price range in the past 12 months?
Race Oncology Ltd. lowest share price was AU$0.92 and its highest was AU$4.90 in the past 12 months.
What is Race Oncology Ltd.’s market cap?
Race Oncology Ltd.’s market cap is AU$518.99M.
When is Race Oncology Ltd.’s upcoming earnings report date?
Race Oncology Ltd.’s upcoming earnings report date is Mar 03, 2026 which is in 79 days.
How were Race Oncology Ltd.’s earnings last quarter?
Race Oncology Ltd. released its earnings results on Aug 26, 2025. The company reported -AU$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.03.
Is Race Oncology Ltd. overvalued?
According to Wall Street analysts Race Oncology Ltd.’s price is currently Overvalued.
Does Race Oncology Ltd. pay dividends?
Race Oncology Ltd. does not currently pay dividends.
What is Race Oncology Ltd.’s EPS estimate?
Race Oncology Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Race Oncology Ltd. have?
Race Oncology Ltd. has 178,348,250 shares outstanding.
What happened to Race Oncology Ltd.’s price movement after its last earnings report?
Race Oncology Ltd. reported an EPS of -AU$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.695%.
Which hedge fund is a major shareholder of Race Oncology Ltd.?
Currently, no hedge funds are holding shares in AU:RAC
Race Oncology Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RAC Sentiment 93%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$83.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
110.34%
12-Months-Change
Fundamentals
Return on Equity
-27.89%
Trailing 12-Months
Asset Growth
-13.54%
Trailing 12-Months
Company Description
Race Oncology Ltd.
Race Oncology Ltd. (RAC) is an Australian pharmaceutical company focused on the development and commercialization of oncology therapies. The company is engaged in the research and development of innovative cancer treatments, with a particular emphasis on the use of its flagship drug, bisantrene, for the treatment of various cancer types. Race Oncology operates within the biotechnology and pharmaceutical sectors, aiming to provide effective solutions to unmet medical needs in oncology.
Technical Analysis
Alterity Therapeutics
―
Prescient Therapeutics Limited
―
EZZ Life Science Holdings Ltd.
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―